Objective: The aim of this investigation was to systematically study and reveal the clinical medication regulations of phlegm and blood stasis and coronary heart disease. Method: We collected the clinical research literatures published from 1995 to 2014 about the treatment of coronary heart disease (CHD)

and analyzed the commonly used clinical prescriptions

the frequency of commonly used traditional Chinese medicine(TCM)

the classification of the commonly used TCM

the addition and subtraction of clinical medicines

the combination with western medicines and the comparison of curative effect between the intervention groups. Result: A total of 42 qualified literatures were referred

including 36 prescriptions with a complete prescription name (including traditional classical name)

eight prescriptions without name as experience prescriptions

involving 104 related drugs

in a sum of 1 587 patients. The most commonly used ten Chinese herb for phlegm and blood stasis of coronary heart disease

by frequency from high to low

are as follows:Rhizome Pinelliae

Radix Salviae Miltiorrhizae

Fructus Trichosanthis

Rhizoma Chuanxiong

Bulbus Allii Macrostemonis

Radix Glycyrrhizae

Poria

Flos Carthami

Pericarpium Citri Reticulatae

Radix Paeoniae Rubra and Radix Angelicae Sinensis. According to the efficacy and the classification of TCM

the most frequently used medicines are ranking as promoting blood circulation to remove blood stasis

eliminating phlegm

qi

tonify deficiency. Conclusion: Treating both phlegm and blood stagnation together is one of the most important differentiation and treatment solutions for coronary heart disease.